$39.85
1.48%
Nasdaq, Apr 21, 08:21 pm CET
ISIN
US88023B1035
Symbol
TEM

Tempus AI Stock price

$40.45
-9.42 18.89% 1M
-7.56 15.75% 6M
+6.69 19.82% YTD
+3.45 9.32% 1Y
+3.45 9.32% 3Y
+3.45 9.32% 5Y
+3.45 9.32% 10Y
Nasdaq, Closing price Thu, Apr 17 2025
-0.41 1.00%
ISIN
US88023B1035
Symbol
TEM

Key metrics

Market capitalization $7.00b
Enterprise Value $7.02b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 10.12
P/S ratio (TTM) P/S ratio 10.09
P/B ratio (TTM) P/B ratio 116.40
Revenue growth (TTM) Revenue growth 30.38%
Revenue (TTM) Revenue $693.40m
EBIT (operating result TTM) EBIT $-688.38m
Free Cash Flow (TTM) Free Cash Flow $-211.17m
Cash position $448.26m
EPS (TTM) EPS $-4.75
P/E forward negative
P/S forward 5.66
EV/Sales forward 5.67
Short interest 15.91%
Show more

Is Tempus AI a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Tempus AI Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Tempus AI forecast:

6x Buy
46%
7x Hold
54%

Analyst Opinions

13 Analysts have issued a Tempus AI forecast:

Buy
46%
Hold
54%

Financial data from Tempus AI

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
693 693
30% 30%
100%
- Direct Costs 325 325
28% 28%
47%
369 369
33% 33%
53%
- Selling and Administrative Expenses 703 703
176% 176%
101%
- Research and Development Expense 317 317
71% 71%
46%
-651 -651
300% 300%
-94%
- Depreciation and Amortization 37 37
12% 12%
5%
EBIT (Operating Income) EBIT -688 -688
251% 251%
-99%
Net Profit -706 -706
230% 230%
-102%

In millions USD.

Don't miss a Thing! We will send you all news about Tempus AI directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tempus AI Stock News

Positive
Finbold
one day ago
Investment strategist Shay Boloor has highlighted three companies driving the “new age” of healthcare, making them must-watch opportunities for investors.
Neutral
Business Wire
3 days ago
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the launch of the Tempus Advisory Board. The Tempus Advisory Board is a vital resource for the company in maintaining high standards and ensuring that the strategy and offerings continue to be grounded in expert knowledge from o...
Neutral
PRNewsWire
6 days ago
Collaboration accelerates insights on clinical benefits of molecular profiling across all major categories of disease SAN DIEGO and CHICAGO , April 15, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) and Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration to accelerate clinical adoption ...
More Tempus AI News

Company Profile

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Head office United States
CEO Eric Lefkofsky
Employees 2,400
Website www.tempus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today